MA32375B1 - Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes - Google Patents

Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes

Info

Publication number
MA32375B1
MA32375B1 MA33391A MA33391A MA32375B1 MA 32375 B1 MA32375 B1 MA 32375B1 MA 33391 A MA33391 A MA 33391A MA 33391 A MA33391 A MA 33391A MA 32375 B1 MA32375 B1 MA 32375B1
Authority
MA
Morocco
Prior art keywords
treatment
oxazolidine
hydroxymethyl
derivatives
intestinal diseases
Prior art date
Application number
MA33391A
Other languages
Arabic (ar)
English (en)
Inventor
Christian Hubschwerlen
Hans Locher
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40955145&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32375(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MA32375B1 publication Critical patent/MA32375B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne des composés de formule i (i) dans laquelle a est n ou ch ; et n vaut 0 ou 1 ; ou leurs sels pharmaceutiquement acceptables, pour la prévention ou le traitement de maladies intestinales qui sont provoquées par des bactéries choisies parmi clostridium difficile, clostridium perfringens ou staphylococcus aureus.
MA33391A 2008-05-09 2010-12-03 Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes MA32375B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IBPCT/IB2008/051854 2008-05-09
PCT/IB2009/051896 WO2009136379A1 (fr) 2008-05-09 2009-05-08 Dérivés de 5-hydroxyméthyl-oxazolidine-2-one pour le traitement de maladies intestinales bactériennes

Publications (1)

Publication Number Publication Date
MA32375B1 true MA32375B1 (fr) 2011-06-01

Family

ID=40955145

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33391A MA32375B1 (fr) 2008-05-09 2010-12-03 Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes

Country Status (24)

Country Link
EP (1) EP2296651B1 (fr)
JP (1) JP4819980B2 (fr)
KR (1) KR101283222B1 (fr)
CN (1) CN102014903B (fr)
AR (1) AR071762A1 (fr)
AU (1) AU2009245351B2 (fr)
BR (1) BRPI0911991B8 (fr)
CA (1) CA2723232C (fr)
CY (1) CY1113197T1 (fr)
DK (1) DK2296651T3 (fr)
ES (1) ES2390405T3 (fr)
HR (1) HRP20120791T1 (fr)
IL (1) IL209105A0 (fr)
MA (1) MA32375B1 (fr)
MX (1) MX2010011918A (fr)
MY (1) MY156304A (fr)
NZ (1) NZ589734A (fr)
PL (1) PL2296651T3 (fr)
PT (1) PT2296651E (fr)
RU (1) RU2527769C2 (fr)
SI (1) SI2296651T1 (fr)
TW (1) TWI447115B (fr)
WO (1) WO2009136379A1 (fr)
ZA (1) ZA201008841B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (fr) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibiotiques a action duale renfermant une oxazolidinone et une quinolone ou une fraction de naphthyridinone
ES2308171T3 (es) 2003-04-30 2008-12-01 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
CA2549675C (fr) † 2003-12-18 2012-11-20 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Antibiotiques hybrides a base d'oxazolidinone-quinolone
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
CN105246476B (zh) 2013-05-28 2019-11-15 莫弗凯姆联合化学股份公司 含噁唑烷酮-喹诺酮的联合疗法在治疗细菌感染中的应用
MX371037B (es) * 2013-05-28 2020-01-14 Morphochem Aktiengesellschaft Fuer Komb Chemie Antibacterianos híbridos de oxazolidinona-quinolona para el tratamiento parenteral o profilaxis de enfermedades bacterianas.
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1156597A3 (ru) * 1982-04-28 1985-05-15 Е.И.Дюпон Де Немур Энд Компани (Фирма) Способ получени производных 3-( @ -алкилсульфонилфенил)оксазолидинона или их фармацевтически приемлемых кислотно-аддитивных солей
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
ATE319710T1 (de) * 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2003031443A1 (fr) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibiotiques a action duale renfermant une oxazolidinone et une quinolone ou une fraction de naphthyridinone
ES2308171T3 (es) * 2003-04-30 2008-12-01 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
ATE544764T1 (de) * 2006-11-10 2012-02-15 Actelion Pharmaceuticals Ltd 5-hydroxymethyloxazolidin-2-onderivate

Also Published As

Publication number Publication date
IL209105A0 (en) 2016-09-29
RU2527769C2 (ru) 2014-09-10
HRP20120791T1 (hr) 2012-11-30
ZA201008841B (en) 2012-05-30
RU2010149994A (ru) 2012-06-20
WO2009136379A1 (fr) 2009-11-12
CN102014903B (zh) 2013-07-10
CY1113197T1 (el) 2016-04-13
EP2296651B1 (fr) 2012-07-18
JP4819980B2 (ja) 2011-11-24
TW200948808A (en) 2009-12-01
PL2296651T3 (pl) 2012-12-31
BRPI0911991B1 (pt) 2020-09-15
JP2011519914A (ja) 2011-07-14
AU2009245351B2 (en) 2015-01-22
AR071762A1 (es) 2010-07-14
CA2723232A1 (fr) 2009-11-12
MY156304A (en) 2016-01-29
CN102014903A (zh) 2011-04-13
BRPI0911991A2 (pt) 2018-02-27
NZ589734A (en) 2012-11-30
HK1155086A1 (en) 2012-05-11
EP2296651A1 (fr) 2011-03-23
SI2296651T1 (sl) 2012-10-30
DK2296651T3 (da) 2012-09-24
MX2010011918A (es) 2010-11-26
KR101283222B1 (ko) 2013-07-11
AU2009245351A1 (en) 2009-11-12
CA2723232C (fr) 2016-08-02
BRPI0911991B8 (pt) 2021-05-25
PT2296651E (pt) 2012-10-01
KR20100137569A (ko) 2010-12-30
ES2390405T3 (es) 2012-11-12
TWI447115B (zh) 2014-08-01

Similar Documents

Publication Publication Date Title
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
DOP2011000102A (es) Compuestos heteroaromaticos espirociclicos fusionados para el tratamiento de infecciones bacterianas
NZ593111A (en) Antibacterial compounds
EA201290267A1 (ru) Производные диоксабицикло[3.2.1]октан-2,3,4-триола
BR112013010310A2 (pt) inibidores de acetil-coa carboxilase de lactama n1/n2
ME01285A (me) Derivati dioksa-bicikl0[3.2.1]oktan-2,3,4-triola
NZ598242A (en) Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MX2010008460A (es) Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
CY1109970T1 (el) Παραγωγα 6-11 δικυκλικου κετολιδιου
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
TN2009000199A1 (en) Heteromonocyclic compound and use thereof
EA201100503A1 (ru) Глюкозидные производные и их применения
BR112013002957A2 (pt) composto de 1,4,5,6-tetrahidro-pirimidin-2-ilamina
GEP20156309B (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MX2021001564A (es) Diazabiciclooctanonas como inhibidores de serina beta-lactamasas.
NZ746906A (en) Oxaborole esters and uses thereof
ME00582A (en) Tricyclic compound and pharmaceutical use thereof
CY1113197T1 (el) Παραγωγα 5-υδροξυμεθυλ- οξαζολιδιν-2-ονης για την αντιμετωπιση βακτηριακων νοσων του εντερου
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
EA201100502A1 (ru) Гликозидные производные и их применения
ATE427315T1 (de) Neue makrolide
EA201000890A1 (ru) Аминотиазолы и их применение
ATE432262T1 (de) Pyrazolphenylderivate als ppar-aktivatoren